Nasdaq: GPAT

GP-Act III Acquisition Corp. (GPAT)

GP-Act III Acquisition Corp. is a public company that reports to the U.S. Securities and Exchange Commission and trades on Nasdaq under the ticker GPAT. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
GPAT
Exchange
Nasdaq
SEC CIK
1834526
Official filings
SEC EDGAR

Research GPAT

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is GP-Act III Acquisition Corp.'s stock ticker?

GP-Act III Acquisition Corp. trades under the ticker symbol GPAT on Nasdaq. Its SEC Central Index Key (CIK) is 1834526.

Where can I read GP-Act III Acquisition Corp.'s SEC filings?

The GPAT SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports GP-Act III Acquisition Corp. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze GPAT's financial statements?

The GPAT Financials page shows GP-Act III Acquisition Corp.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does GPAT compare with its peers and the market?

The GPAT Peer Comparison page lines GP-Act III Acquisition Corp. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.